Company / Current Assets
FATE THERAPEUTICS INC Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$208.7M
FY2025
5-year range
$208.7M / $633.4M
FY2021-FY2025
Trend
-28.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has declined for 4 consecutive years, from $633M in FY2021 to $209M in FY2025.
Based on SEC 10-K filings.
$209M in FY2025 with a 5-year CAGR of -15.8%.
Declined from $332M to $209M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -25.4%
- 5-Year CAGR
- -15.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- FATE THERAPEUTICS INC's current assets has declined for 4 consecutive years.
- 5-year CAGR of -15.8%, indicating a declining trend.
- In FY2025, current assets decreased 28.5% year-over-year.
- Peak current assets was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 632.81 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $208.7M | -28.5% |
| FY2024 | $291.9M | -12.0% |
| FY2023 | $331.5M | -34.0% |
| FY2022 | $502.1M | -20.7% |
| FY2021 | $633.4M | +28.1% |
| FY2020 | $494.3M | +117.7% |
| FY2019 | $227.1M | +10.7% |
| FY2018 | $205.2M | +100.0% |
| FY2017 | $102.6M | +9.9% |
| FY2016 | $93.3M | +42.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026